Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Z Zeng, J Lin, J Chen - Annals of hematology, 2013 - Springer
Multiple myeloma (MM) is an incurable disease with a poor survival, which has not been
affected even by high-dose chemotherapy. This systematic review was performed to assess …
被引用次数：41 相关文章

Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Z Zeng, J Lin, J Chen - Annals of Hematology, 2013 - search.proquest.com
Multiple myeloma (MM) is an incurable disease with a poor survival, which has not been
affected even by high-dose chemotherapy. This systematic review was performed to assess …

Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.

Z Zeng, J Lin, J Chen - Annals of Hematology, 2013 - europepmc.org
Multiple myeloma (MM) is an incurable disease with a poor survival, which has not been
affected even by high-dose chemotherapy. This systematic review was performed to assess …

Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Z Zeng, J Lin, J Chen - Annals of Hematology, 2013 - infona.pl
Multiple myeloma (MM) is an incurable disease with a poor survival, which has not been
affected even by high-dose chemotherapy. This systematic review was performed to assess …

Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Z Zeng, J Lin, J Chen - Annals of hematology, 2013 - pubmed.ncbi.nlm.nih.gov
Multiple myeloma (MM) is an incurable disease with a poor survival, which has not been
affected even by high-dose chemotherapy. This systematic review was performed to assess …

Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.

Z Zeng, J Lin, J Chen - Annals of Hematology, 2013 - search.ebscohost.com
Multiple myeloma (MM) is an incurable disease with a poor survival, which has not been
affected even by high-dose chemotherapy. This systematic review was performed to assess …

[引用][C] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

Z Zeng, J Lin, J Chen - Annals of hematology, 2013 - Springer